Expertise in
25
conditions

Dr. Mandy D. Robertson

Hematology
Drug Therapy Systems
265 Cohasset Rd, 
Chico, CA 
Accepting New Patients
Offers Telehealth
Expertise in
25
conditions
Drug Therapy Systems
265 Cohasset Rd, 
Chico, CA 

Overview

Mandy Robertson is a Hematologist practicing medicine in Chico, California.

Dr. Robertson is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Chronic B-Cell Leukemia (CBCL).

She is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials. Dr. Robertson is currently accepting new patients.

Graduate Institution

University Of Florida College Of Medicine

Specialties

Hematology

Licenses

Internal Medicine in WA

Hospital Affiliations

Tacoma General Allenmore Hospital
Swedish Issaquah
Swedish Medical Center
Mid-Columbia Medical Center
Enloe Health

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Drug Therapy Systems
265 Cohasset Rd, Chico, CA 95926
Other Locations
Vista Oncology Inc PS
141 Lilly Rd NE, Olympia, WA 98506

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: September 04, 2026
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Study Phase: Phase 3
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Behavioral
Study Phase: Phase 3
View 7 Less Clinical Trials

1 Total Publications

Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden.
Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden.
Journal: Clinical colorectal cancer
Published: June 06, 2019
Similar Doctors
Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required

Edgar O. Vyhmeister MD

265 Cohasset Rd Ste 170, 
Chico, CA 
 (0.1 miles away)
530-332-3890
Languages Spoken:
English, Bahasa, French, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

William Bonis is a Hematologist practicing medicine in Chico, California. Dr. Bonis is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Non-Hodgkin Lymphoma. Dr. Bonis is currently accepting new patients.

Expertise in
86
conditions
Dr. David L. Campbell
Hematology | Oncology
Expertise in
86
conditions
Dr. David L. Campbell
Hematology | Oncology
Referral may be required
Before you request

Cancer Clinic - Dignity Health Medical Group - Grass Valley, CA

155 Glasson Way, Suite L10, 
Grass Valley, CA 
 (56.1 miles away)
530-274-6677
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

My patients are my customers and the customer is always right . I strive to provide my patients with the best cancer care possible. Patients with cancer can be confused and frustrated with the many different treatment options and I do my best to empower my patients with the knowledge that allows them to make the best choices for them. Dr. Campbell is highly rated in 86 conditions, according to our data. His clinical expertise encompasses Gastric Lymphoma, Paget Disease of the Breast, Non-Hodgkin Lymphoma, and Inflammatory Breast Cancer. Dr. Campbell is board certified in Internal Medicine (Sub: Medical Oncology). Dr. Campbell is currently accepting new patients.

Expertise in
25
conditions
Dr. Madhu Jodhani
Hematology | Oncology
Expertise in
25
conditions
Dr. Madhu Jodhani
Hematology | Oncology
Referral may be required

Yuba-Sutter Oncology Center Inc.

481 Plumas Blvd Ste 102, 
Yuba City, CA 
 (54.1 miles away)
530-671-5175
Experience:
47+ years
Languages Spoken:
English
See accepted insurances

Madhu Jodhani is a Hematologist and an Oncologist practicing medicine in Yuba City, California. He has been practicing medicine for over 47 years. Dr. Jodhani is highly rated in 25 conditions, according to our data. His clinical expertise encompasses RUNX1 Familial Platelet Disorder, Inflammatory Breast Cancer, Anemia, and Polycythemia Vera.

Frequently Asked Questions about Dr. Mandy D. Robertson

How do I make an appointment with Dr. Mandy D. Robertson?

You can book an appointment with Dr. Mandy D. Robertson by calling their office at 530-332-3808. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mandy D. Robertson a top-rated expert for Follicular Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mandy D. Robertson is classified as an Distinguished expert for Follicular Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mandy D. Robertson specialize in?

While Dr. Mandy D. Robertson is a Hematology, they have specific expertise in Follicular Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Mandy D. Robertson participate in research or clinical trials?

Yes. Dr. Mandy D. Robertson has published 1 articles and abstracts on conditions like Follicular Lymphoma. You can view a list of Dr. Mandy D. Robertson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mandy D. Robertson accept my insurance?

Dr. Mandy D. Robertson accepts most major insurance plans, including Aetna and Cambia Health Solutions. We recommend calling the office directly at 530-332-3808 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Robertson's expertise for a condition
ConditionClose
    View All 24 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile